483 related articles for article (PubMed ID: 30024460)
21. Analysis of HSP27 and the Autophagy Marker LC3B
Livingston JA; Wang WL; Tsai JW; Lazar AJ; Leung CH; Lin H; Advani S; Daw N; Santiago-O'Farrill J; Hollomon M; Gordon NB; Kleinerman ES
Mol Cancer Ther; 2018 Jun; 17(6):1315-1323. PubMed ID: 29592877
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
Li Z; Jia M; Wu X; Cui J; Pan A; Li L
Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
[TBL] [Abstract][Full Text] [Related]
23. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
[TBL] [Abstract][Full Text] [Related]
24. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
25. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous necrosis and additional tumor necrosis induced by preoperative chemotherapy for osteosarcoma: a case-control study.
Song WS; Jeon DG; Cho WH; Kong CB; Cho SH; Lee SY; Lee SY
J Orthop Sci; 2015 Jan; 20(1):174-9. PubMed ID: 25355661
[TBL] [Abstract][Full Text] [Related]
27. Survival, complications and functional outcomes of cemented megaprostheses for high-grade osteosarcoma around the knee.
Zhang C; Hu J; Zhu K; Cai T; Ma X
Int Orthop; 2018 Apr; 42(4):927-938. PubMed ID: 29427125
[TBL] [Abstract][Full Text] [Related]
28. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
J Surg Oncol; 2008 Apr; 97(5):456-61. PubMed ID: 18270971
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and prognostic values of fibronectin and integrin αvβ3 expression in primary osteosarcoma.
Shi K; Wang SL; Shen B; Yu FQ; Weng DF; Lin JH
World J Surg Oncol; 2019 Jan; 17(1):23. PubMed ID: 30691475
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.
Yao D; Cai GH; Chen J; Ling R; Wu SX; Li YP
Int J Clin Exp Pathol; 2014; 7(10):6725-33. PubMed ID: 25400752
[TBL] [Abstract][Full Text] [Related]
31. High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study.
Boye K; Del Prever AB; Eriksson M; Saeter G; Tienghi A; Lindholm P; Fagioli F; Skjeldal S; Ferrari S; Hall KS
Pediatr Blood Cancer; 2014 May; 61(5):840-5. PubMed ID: 24254749
[TBL] [Abstract][Full Text] [Related]
32. Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jung ST; Jeon DG
J Orthop Sci; 2009 May; 14(3):292-7. PubMed ID: 19499296
[TBL] [Abstract][Full Text] [Related]
33. Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon.
Abou Ali B; Salman M; Ghanem KM; Boulos F; Haidar R; Saghieh S; Akel S; Muwakkit SA; El-Solh H; Saab R; Tamim H; Abboud MR
J Glob Oncol; 2019 Apr; 5():1-8. PubMed ID: 30946633
[TBL] [Abstract][Full Text] [Related]
34. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
[TBL] [Abstract][Full Text] [Related]
35. Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities.
Serra M; Scotlandi K; Reverter-Branchat G; Ferrari S; Manara MC; Benini S; Incaprera M; Bertoni F; Mercuri M; Briccoli A; Bacci G; Picci P
J Clin Oncol; 2003 Feb; 21(3):536-42. PubMed ID: 12560446
[TBL] [Abstract][Full Text] [Related]
36. Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Xu M; Xu S; Yu X
World J Surg Oncol; 2014 Nov; 12():341. PubMed ID: 25391880
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases.
Ward WG; Mikaelian K; Dorey F; Mirra JM; Sassoon A; Holmes EC; Eilber FR; Eckardt JJ
J Clin Oncol; 1994 Sep; 12(9):1849-58. PubMed ID: 8083708
[TBL] [Abstract][Full Text] [Related]
38. Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
Longhi A; Bielack SS; Grimer R; Whelan J; Windhager R; Leithner A; Gronchi A; Biau D; Jutte P; Krieg AH; Klenke FM; Grignani G; Donati DM; Capanna R; Casanova J; Gerrand C; Bisogno G; Hecker-Nolting S; De Lisa M; D'Ambrosio L; Willegger M; Scoccianti G; Ferrari S
Eur J Cancer; 2017 Mar; 74():9-16. PubMed ID: 28167373
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]